PEA Promote Gastrointestinal Function Recovered After Colorectal Cancer Operation
Perioperative Electroacupuncture Promotes Early Gastrointestinal Function Rehabilitation After Radical Resection of Colorectal Cancer: a Pilot Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
To investigate whether perioperative electroacupuncture is more effective than postoperative electroacupuncture in improving gastrointestinal function after colorectal cancer operation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable colorectal-cancer
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2021
CompletedFirst Posted
Study publicly available on registry
March 30, 2021
CompletedStudy Start
First participant enrolled
July 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedJanuary 10, 2023
January 1, 2023
2 years
February 23, 2021
January 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time to first flatus (TFF)
time to first flatus
Day 3
Secondary Outcomes (15)
Recovery time of postoperative bowel sounds
Day 3
Time of first postoperative defecation
Day 3
Dietary recovery
Day 3
Postoperative gastrointestinal dysfunction
Day 3
Quality of life scale 1
"Day 0","Day 3","Day 7"
- +10 more secondary outcomes
Study Arms (2)
Routine perioperative management and PEA
EXPERIMENTALRoutine perioperative management and perioperative electroacupuncture (preoperative, intraoperative, postoperative);
Routine perioperative management and postEA
ACTIVE COMPARATORRoutine perioperative management and postoperative electroacupuncture
Interventions
Routine perioperative management: All patients were given perioperative fluid rehydration and nutritional support to correct acid-base imbalance, electrolyte disturbance, anti-infection, hemostasis and other symptomatic treatment; electroacupuncture protocol: Preoperation:RN 6 + RN 4 +ST30 + ST 36+ Hegu (bilateral),De qi, electroacupuncture, continuous wave, 5Hz, 30min before surgery at 19:00 PM Inoperatively: LI 4+ PC 6 + ST36 + GB 34 (bilateral) ,Deqi, electroacupuncture with density wave, 2/100Hz, 30 minutes before operation to the end of the operation Postoperative: LI 4 +SJ 6 + ST 6 + ST 37(Left);LI 4 +SJ 6 + ST 6 + ST 37(Right)(alternated on both sides per 12h) Deqi, electroacupuncture, continuous wave, 5Hz, 30min,19:00 on the left side and 07:00 on the next day after surgery,until to first flatus (FF)
Routine perioperative management: All patients were given perioperative fluid rehydration and nutritional support to correct acid-base imbalance, electrolyte disturbance, anti-infection, hemostasis and other symptomatic treatment; electroacupuncture protocol: Postoperative: LI 4 +SJ 6 + ST 6 + ST 37(Left);LI 4 +SJ 6 + ST 6 + ST 37(Right)(alternated on both sides per 12h) Deqi, electroacupuncture, continuous wave, 5Hz, 30min,19:00 on the left side and 07:00 on the next day after surgery,until to first flatus (FF)
Eligibility Criteria
You may qualify if:
- Patients who meet the diagnostic criteria of colorectal cancer and need elective radical resection of colorectal cancer;
- ≤ age≤79, gender is not limited;
- Understand and agree to participate in the study and sign the informed consent;
- No previous history of abdominal surgery and no abdominal adhesion;
You may not qualify if:
- Patients with mental illness;
- Patients requiring combined resection of other organs;
- Participated in or is participating in other clinical researchers in the previous 3 months
- People who have received acupuncture (including electroacupuncture) in the past;
- Other treatment options are being used (chemotherapy, radiotherapy, etc.) Those who meet any of the above criteria will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jia Zhou, MD
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2021
First Posted
March 30, 2021
Study Start
July 31, 2021
Primary Completion
July 31, 2023
Study Completion
October 31, 2023
Last Updated
January 10, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 month later for one year
- Access Criteria
- contact with the principal investigator
Through the article publication